1. Home
  2. STRO vs MX Comparison

STRO vs MX Comparison

Compare STRO & MX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • MX
  • Stock Information
  • Founded
  • STRO 2003
  • MX 2003
  • Country
  • STRO United States
  • MX South Korea
  • Employees
  • STRO 306
  • MX N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • MX Semiconductors
  • Sector
  • STRO Health Care
  • MX Technology
  • Exchange
  • STRO Nasdaq
  • MX Nasdaq
  • Market Cap
  • STRO 165.7M
  • MX 154.4M
  • IPO Year
  • STRO 2018
  • MX N/A
  • Fundamental
  • Price
  • STRO $2.01
  • MX $4.16
  • Analyst Decision
  • STRO Strong Buy
  • MX Strong Buy
  • Analyst Count
  • STRO 7
  • MX 2
  • Target Price
  • STRO $12.14
  • MX $7.50
  • AVG Volume (30 Days)
  • STRO 984.3K
  • MX 209.9K
  • Earning Date
  • STRO 11-13-2024
  • MX 01-29-2025
  • Dividend Yield
  • STRO N/A
  • MX N/A
  • EPS Growth
  • STRO N/A
  • MX N/A
  • EPS
  • STRO N/A
  • MX N/A
  • Revenue
  • STRO $160,955,000.00
  • MX $219,520,000.00
  • Revenue This Year
  • STRO N/A
  • MX $3.09
  • Revenue Next Year
  • STRO N/A
  • MX $10.06
  • P/E Ratio
  • STRO N/A
  • MX N/A
  • Revenue Growth
  • STRO 230.90
  • MX N/A
  • 52 Week Low
  • STRO $1.67
  • MX $3.56
  • 52 Week High
  • STRO $6.13
  • MX $7.10
  • Technical
  • Relative Strength Index (RSI)
  • STRO 46.47
  • MX 55.33
  • Support Level
  • STRO $1.72
  • MX $3.91
  • Resistance Level
  • STRO $2.15
  • MX $4.40
  • Average True Range (ATR)
  • STRO 0.14
  • MX 0.15
  • MACD
  • STRO 0.05
  • MX 0.01
  • Stochastic Oscillator
  • STRO 70.83
  • MX 57.89

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About MX Magnachip Semiconductor Corporation

MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.

Share on Social Networks: